Skip to main content
. 2019 Sep 1;11(9):443. doi: 10.3390/pharmaceutics11090443

Table 2.

The IC50 values determined for SP and various radiobioconjugates based on SP analogues [53].

Substance IC50 ± SEM [nM]
Substance P 2.7 ± 0.22
111In-DOTAGA-Substance P 1.1
111In-DOTAGA-[Met(O2)11]-Substance P 9.8 ± 1.00
111In-DOTA-[Met(O2)11]-Substance P 3.55 ± 0.45
111In-DOTA-[Sar9]-Substance P 3.20 ± 0.30
111In-DOTA-[Thi8]-Substance P 7.30 ± 2.00
111In-DOTA-[Thi7]-Substance P 9.40 ± 1.60
111In-DOTA-[Sar9,Met(O2)11]-Substance P 2.00 ± 0.00
111In-DOTA-[Thi8,Met(O2)11]-Substance P 0.78 ± 0.03
111In-DOTA-[Thi8,Sar9]-Substance P 3.40 ± 0.40
111In-DOTA-[Thi7,Thi8]-Substance P 7.70 ± 0.70